Ken Kato
Impact in
Papers in
- Co-authors
- Yasuhide Yamada (82 shared papers)Yuko Kitagawa (72 shared papers)Yasuhiro Shimada (75 shared papers)Tetsuya Hamaguchi (90 shared papers)Takashi Kojima (66 shared papers)Satoru Iwasa (99 shared papers)Kei Muro (38 shared papers)Yuichiro� Doki (19 shared papers)
- Journals
- Journal of Clinical Oncology (99 papers)Annals of Oncology (34 papers)Esophagus (27 papers)Japanese Journal of Clinical Oncology (24 papers)Cancer Science (21 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Ken Kato
473 papers receiving 13.3k citations
Ken Kato's Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 3.8k
- Surgery 5.2k
- Pulmonary and Respiratory Medicine 3.0k
- Cancer Research 1.4k
- Gastroenterology 366
Countries citing papers authored by Ken Kato
This map shows the geographic impact of Ken Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Kato more than expected).
Fields of papers citing papers by Ken Kato
This network shows the impact of papers produced by Ken Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Kato. The network helps show where Ken Kato may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Kato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 513 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2019 | 786 |
| 2 | Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2 Hit paper breakdown → | 2018 | 412 |
| 3 | Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1 Hit paper breakdown → | 2018 | 376 |
| 4 | Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus Hit paper breakdown → | 2018 | 365 |
| 5 | Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial Hit paper breakdown → | 2017 | 294 |
| 6 | 2010 | 271 | |
| 7 | 2018 | 238 | |
| 8 | 2013 | 233 | |
| 9 | 2018 | 231 | |
| 10 | 2007 | 213 | |
| 11 | 2010 | 189 | |
| 12 | 2018 | 183 | |
| 13 | 2011 | 172 | |
| 14 | 2013 | 167 | |
| 15 | 2016 | 166 | |
| 16 | 2012 | 160 | |
| 17 | 2019 | 157 | |
| 18 | Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. | 1999 | 157 |
| 19 | 2009 | 154 | |
| 20 | 1999 | 134 |
About Ken Kato
Ken Kato is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 513 papers that have together received 13.5k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (203 papers), Gastric Cancer Management and Outcomes (140 papers), Cancer Immunotherapy and Biomarkers (89 papers), Colorectal Cancer Treatments and Studies (59 papers), Lung Cancer Treatments and Mutations (40 papers), Esophageal and GI Pathology (29 papers), Pancreatic and Hepatic Oncology Research (27 papers) and Gastrointestinal Tumor Research and Treatment (23 papers). The work is most often cited by research in Oncology (3.8k citations), Surgery (5.2k citations), Pulmonary and Respiratory Medicine (3.0k citations), Cancer Research (1.4k citations) and Gastroenterology (366 citations). Ken Kato has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yasuhide Yamada, Yuko Kitagawa, Yasuhiro Shimada, Tetsuya Hamaguchi, Takashi Kojima, Satoru Iwasa, Kei Muro, Yuichiro� Doki, Hiroyuki Daiko and Yasuo Hamamoto. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Esophagus, Japanese Journal of Clinical Oncology and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.